Gland Pharma Ltd.

₹1528.7

Gland Pharma Ltd.

₹1528.7

₹1528.7

-17.9 (-1.16%) - 24 May 2025 02:33 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹ 25,186 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 23.11
P/B Ratio 2.80
Enterprise Value ₹ -1,467 Cr.
ROE % 12.31
RSI Value 60.48
EMA 50 1494.31
EMA 200 1628.7
Market Cap. ₹ 25,186 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 36.05
P/B Ratio 2.89
Enterprise Value ₹ -1,351 Cr.
ROE % 9.26
RSI Value 60.48
EMA 50 1494.31
EMA 200 1628.7

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.